Status: Recruiting
Concomitant HPV Vaccination and HPV Screening HPV Infection and Cervical Cancer in Sweden
The study aims to evaluate whether organised, concomitant HPV vaccination and HPV screening offered to all resident women aged 22-27 will result in a more rapid elimination of HPV infection in Sweden. This objective will be examined at the population level.
Participants needed: 150,000
Trial details
Phase: Phase 4Age: 22-27Biological sex: FemaleType: InterventionalSponsor: Miriam ElfströmUpdated: Sep 16, 2021Locations: 1
Eligibility criteria
Eligible women will include resident women within the age range of 22-26, who ha...
Known history of severe allergic reaction or hypersensitivity to any of the comp... [+5]